Skip to Main Content
Services Talent Knowledge
Site Search
Menu

PressRelease

April 18, 2013

Associate Mark T. Whitford Jr. Honored as "Up and Coming Attorney"

Rochester, New York - April 18, 2013 - Mark T. Whitford Jr., of Hiscock & Barclay LLP, was selected as an Up & Coming Attorney by The New York Daily Record.

Whitford was honored April 18 at the Hyatt Regency in Rochester.

Whitford, who practices in the firm's Rochester office, focuses on insurance coverage disputes, litigated tort defense and appellate advocacy.

A graduate of the State University of New York at Buffalo and the University of Connecticut School of Law, Whitford represents national and regional insurers, as well as individuals and businesses throughout the state. In addition, Whitford practices before the state and federal appellate courts, building upon his former clerkship with the Appellate Division, Third Department.

"I am very honored to have been nominated and selected for this award, especially because I know how many talented young attorneys we have in our community," said Whitford.

"We are very proud of what Mark has accomplished since joining the firm. He has the type of talent we have been fortunate to attract to Hiscock & Barclay and to the Rochester legal community," said James S. Grossman, managing director of Hiscock & Barclay's Rochester office.

Whitford can be reached at 585-295-4449 or mwhitford@hblaw.com.

Subscribe

Click here to sign up for alerts, blog posts, and firm news.

Featured Media

Alerts

Website Accessibility Lawsuits: Several "Tester" Plaintiffs—Sandra Ford, Z'Leah Liburd, Livingston Bennett, Brandi Major, and Joshua Espinal—Targeting Businesses in Recent Flurry of Lawsuits

Alerts

Year-End Focus for 403(b) Plan Sponsors: Two Critical Document Deadlines and Typical Year-End Compliance Review

Alerts

Second Circuit Reverses Award of Attorney's Fees in Coverage Dispute Between Liability Insurers

Alerts

Federal Court Narrows Scope of Insurers' Privilege Claims in COVID-19 Coverage Litigation

Alerts

AstraZeneca Escalates FARXIGA® Audit Demands: What Pharmacies Need to Know Now

Alerts

Update on the Evolving Guidance for H-1B Entry Restrictions Under September 19 Presidential Proclamation